EXPANDED PROGRAM ON IMMUNIZATION — Vaccine Importer Profile
Pharmaceutical Importer · #5 buyer for Vaccine · $3.0M import value · 59 shipments · PAKISTAN · DGFT Verified
EXPANDED PROGRAM ON IMMUNIZATION is the #5 importer of Vaccine from India with $3.0M in import value and 59 verified shipments. EXPANDED PROGRAM ON IMMUNIZATION holds a 0.4% market share in Vaccine imports based in PAKISTAN. The company sources from 5 verified suppliers across 19 formulations shipped to 1 country.
EXPANDED PROGRAM ON IMMUNIZATION — Vaccine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Vaccine to EXPANDED PROGRAM ON IMMUNIZATION?
Verified from 59 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| BIOLOGICAL E. LIMITED | $1.3M | 25 | 42.4% |
| BHARAT BIOTECH INTERNATIONAL LIMITED | $850.0K | 17 | 28.8% |
| PANACEA BIOTEC LIMITED | $350.0K | 7 | 11.9% |
| SERUM INSTITUTE OF INDIA PRIVATE LIMITED | $250.0K | 5 | 8.5% |
| BIOLOGICAL E LIMITED | $250.0K | 5 | 8.5% |
EXPANDED PROGRAM ON IMMUNIZATION sources Vaccine from 5 verified Indian suppliers based on 59 customs records. The primary supplier is BIOLOGICAL E. LIMITED accounting for 42.4% of imports.
How Does EXPANDED PROGRAM ON IMMUNIZATION Compare to Nearest Vaccine Importers?
Buyers ranked immediately above and below #5 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | MINISTRY OF HEALTH | GAMBIA | $4.5M | 91 | $50.0K |
| 4 | D.G. CENTRAL MEDICAL STORES DEPT | BANGLADESH | $2.7M | 54 | $50.0K |
| 5 | EXPANDED PROGRAM ON IMMUNIZATION ★ | PAKISTAN | $2.4M | 48 | $50.0K |
| 9 | XXICEXXSUPXXY DXXISIXX | AFGHANISTAN | $2.4M | 48 | $50.0K |
| 11 | EXPANDED PROGRAMME ON IMMUNIZATION | PAKISTAN | $2.3M | 45 | $50.0K |
EXPANDED PROGRAM ON IMMUNIZATION ranks #5 among 2,202 Vaccine importers from India. Average shipment value of $50.0K compared to the market average of $17.3K. The closest competitors by value are MINISTRY OF HEALTH and D.G. CENTRAL MEDICAL STORES DEPT.
Where Does EXPANDED PROGRAM ON IMMUNIZATION Import Vaccine To?
Destination countries from 59 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| PAKISTAN | $3.0M | 59 | 100.0% |
EXPANDED PROGRAM ON IMMUNIZATION imports Vaccine to 1 country. The primary destination is PAKISTAN receiving 100.0% of shipments worth $3.0M.
What Vaccine Formulations Does EXPANDED PROGRAM ON IMMUNIZATION Import?
| Formulation | Value | Shipments |
|---|---|---|
| TYPBAR TCV-2.5 ML VIAL (TYPHOID VI CONJUGATE VACCINE)VLS | $450.0K | 9 |
| EASY FIVE TT VACCINE DTwP-HepB-HIB PENTA | $300.0K | 6 |
| MR VACCINE MEASLES AND RUBELLA VACCINE COMBINED VIAL OF 5 DOSES WITH DILUENT. WITH VACCINE VIAL MONITOR (VVM) | $300.0K | 6 |
| DTP HEPB HIB PENTAVALENT VACCINE FULLYLIQUID COMBINATION VACCINE SINGLE DOSEVIAL 0 5ML VIAL PEDIATRIC DOSE | $250.0K | 5 |
| DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLY | $200.0K | 4 |
| TYPBAR TCV-2.5 ML VIAL (TYPHOID VI CONJUGATE VACCINE) | $200.0K | 4 |
| DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLYLIQUID COMBINATION VACCINE,SINGLE DOSEVIAL(0.5ML) VIAL,PEDIATRIC DOSE ** | $200.0K | 4 |
| DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLYLIQUID COMBINATION VACCINE,SINGLE DOSEVIAL(0.5ML) VIAL,PEDIATRIC DOSE**** | $200.0K | 4 |
| [MIXED VACCINES FOR DIPHTHERIA AND TETAN | $100.0K | 2 |
| TYPBAR TCV-2.5 ML VIAL TYPHOID VI CONJUGATE VACCINE | $100.0K | 2 |
EXPANDED PROGRAM ON IMMUNIZATION imports 19 distinct Vaccine formulations from India. The top formulation is TYPBAR TCV-2.5 ML VIAL (TYPHOID VI CONJUGATE VACCINE)VLS with 9 shipments worth $450.0K.
Who Are the Top Buyers of Vaccine from India and How Much Does EXPANDED PROGRAM ON IMMUNIZATION Import?
India exported $38.1M worth of Vaccine through 14,355 shipments from 325 suppliers to 192 countries, serving 2,202 buyers globally. EXPANDED PROGRAM ON IMMUNIZATION imports $3.0M of this total, accounting for 0.4% of India's Vaccine exports with 59 shipments from PAKISTAN. This is verified from 59 customs shipment records covering 19 distinct formulations.
What Is the Average Order Value for EXPANDED PROGRAM ON IMMUNIZATION's Vaccine Imports?
EXPANDED PROGRAM ON IMMUNIZATION's average Vaccine order value is $50.0K per consignment, based on 59 shipments totaling $3.0M. EXPANDED PROGRAM ON IMMUNIZATION is based in PAKISTAN and ranks #5 among all Vaccine importers from India by value. The company sources from 5 verified suppliers in India.
Who Supplies Vaccine to EXPANDED PROGRAM ON IMMUNIZATION?
EXPANDED PROGRAM ON IMMUNIZATION sources Vaccine from 5 verified Indian suppliers: BIOLOGICAL E. LIMITED ($1.3M, 42.4%), BHARAT BIOTECH INTERNATIONAL LIMITED ($850.0K, 28.8%), PANACEA BIOTEC LIMITED ($350.0K, 11.9%), SERUM INSTITUTE OF INDIA PRIVATE LIMITED ($250.0K, 8.5%), BIOLOGICAL E LIMITED ($250.0K, 8.5%). This is based on 59 customs records.
How Does EXPANDED PROGRAM ON IMMUNIZATION Compare to Other Vaccine Importers?
EXPANDED PROGRAM ON IMMUNIZATION ranks #5 among 2,202 Vaccine importers from India with a 0.4% market share. The top 3 importers are NATIONAL PRIMARY HEALTH CARE ($6.3M), UNICEF SUPPLY DIVISION ($5.0M), MINISTRY OF HEALTH ($4.5M). EXPANDED PROGRAM ON IMMUNIZATION processed 59 shipments from PAKISTAN.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vaccine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vaccine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: EXPANDED PROGRAM ON IMMUNIZATION matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as EXPANDED PROGRAM ON IMMUNIZATION's capped import value divided by total capped export value for Vaccine across all Indian exporters.
- 5.Verified Records: This page is backed by 59 individual customs records matching EXPANDED PROGRAM ON IMMUNIZATION importing Vaccine, covering 19 formulations from 5 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 192+ countries, 2,202+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vaccine Import Data for EXPANDED PROGRAM ON IMMUNIZATION
Access order-level details, pricing data, supplier connections, and competitive analysis for EXPANDED PROGRAM ON IMMUNIZATION's Vaccine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
EXPANDED PROGRAM ON IMMUNIZATION
Company Profile
Multiple products · $0 total trade · Multiple categories
EXPANDED PROGRAM ON IMMUNIZATION × Vaccine
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for EXPANDED PROGRAM ON IMMUNIZATION.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vaccine. For current order-level data, contact TransData Nexus.